| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ATYR | aTYR PHARMA INC | Chief Financial Officer | $143K | -$4.74K | -3.21% | Feb 3, 2025 |
| TLPH | TALPHERA, INC. | Director | $7.62K | Oct 23, 2025 | ||
| CUE | Cue Biopharma, Inc. | Director | Jun 4, 2025 | |||
| OTIC | OTONOMY, INC. | Director | Jun 21, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|